The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme.

MLA

Olmez, O., et al. “The Immunohistochemical Expression of C-Met Is an Independent Predictor of Survival in Patients with Glioblastoma Multiforme.” Clinical & Translational Oncology, vol. 16, no. 2, Feb. 2014, pp. 173–77. EBSCOhost, https://doi.org/10.1007/s12094-013-1059-4.

APA

Olmez, O., Cubukcu, E., Evrensel, T., Kurt, M., Avci, N., Tolunay, S., Bekar, A., Deligonul, A., Hartavi, M., Alkis, N., & Manavoglu, O. (2014). The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme. Clinical & Translational Oncology, 16(2), 173–177. https://doi.org/10.1007/s12094-013-1059-4

Chicago

Olmez, O., E. Cubukcu, T. Evrensel, M. Kurt, N. Avci, S. Tolunay, A. Bekar, et al. 2014. “The Immunohistochemical Expression of C-Met Is an Independent Predictor of Survival in Patients with Glioblastoma Multiforme.” Clinical & Translational Oncology 16 (2): 173–77. doi:10.1007/s12094-013-1059-4.